In This Episode
Oxford University’s vaccine could be up to 90 per cent effective, data from phase III trials shows today. With the UK government ordering 100 million doses of the jab, could it mean a return to normality is on the horizon? Katy Balls speaks to Fraser Nelson and James Forsyth.
Comments
A blooming good offer
Join the conversation with other Spectator readers by getting the next 3 months for £3.
CLAIM OFFER 3 months for £3Already a subscriber? Log in